Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Clinical Reviews in Allergy & Immunology

Issue 2/2009

Anti-Factor VIII Antibodies (Inhibitors) in Hemophilia; Guest Editor: Svini V. Kaveri

Content (9 Articles)

Anti-factor VIII Antibodies (Inhibitors) in Hemophilia A: In Dire Need of Basic and Therapeutic Research

Srini V. Kaveri

Immune Response to FVIII in Hemophilia A: An Overview of Risk Factors

Kanjaksha Ghosh, Shrimati Shetty

Characteristics, Mechanisms of Action, and Epitope Mapping of Anti-factor VIII Antibodies

Géraldine Lavigne-Lissalde, Chantal Rothschild, Claire Pouplard, Priscilla Lapalud, Yves Gruel, Jean-François Schved, Claude Granier

B-Cell and T-Cell Epitopes in Anti-factor VIII Immune Responses

Kathleen P. Pratt, Arthur R. Thompson

Erratum

Varied Immune Response to FVIII: Presence of Proteolytic Antibodies Directed to Factor VIII in Different Human Pathologies

Bharath Wootla, Desirazu Narasimha Rao, Alain Friboulet, Taizo Uda, Sébastien Lacroix-Desmazes, Srini V. Kaveri

Varied Immune Response to FVIII: Presence of Proteolytic Antibodies Directed to Factor VIII in Different Human Pathologies

Bharath Wootla, Narasimha Rao Desirazu, Alain Friboulet, Taizo Uda, Sébastien Lacroix-Desmazes, Srini V. Kaveri

A Cellular Viewpoint of Anti-FVIII Immune Response in Hemophilia A

Sebastien André, Yann Meslier, Jordan D. Dimitrov, Yohann Repessé, Srinivas V. Kaveri, Sebastien Lacroix-Desmazes, Suryasarathi Dasgupta

Factor VIII Inhibitors: Risk Factors and Methods for Prevention and Immune Modulation

Ai Hong Zhang, Jonathan Skupsky, David W. Scott

Management of Haemophilia A-Inhibitor Patients: Clinical and Regulatory Perspectives

Zera Tellier, Marie-Hélène André, Benoît Polack

Aug 09
Issue: 1/2009
Atherosclerosis and Autoimmunity
Dec 09
Issue: 3/2009
Pulmonary Function Testing; Topic Editor: Richard E. Kanner, MD

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits